Creon DR 24,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DB26FV90T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,212
Award facts
- Contract value 100% obligated
- $1,212.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,212.12 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon (pancrelipase) 100s on October 24, 2025, with completion targeted for October 27, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence through its extensive portfolio of medical product deliveries to the Defense Logistics Agency and the Medical Supply Chain. As a critical vendor for federal medical procurement, the company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The SPE2DX IDC enables AmerisourceBergen to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible pharmaceutical procurement capabilities across multiple therapeutic domains worldwide.
Quick answers
Who was awarded contract SPE2DB26FV90T?
SPE2DB26FV90T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FV90T worth?
The government has obligated $1,212 on SPE2DB26FV90T.
Is contract SPE2DB26FV90T an order under another contract?
Yes. SPE2DB26FV90T is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB26FV90T competed?
The extent of competition for SPE2DB26FV90T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award